End-Stage Renal Disease and Dialysis

  • Farahnak Assadi


An 18-year old male with end-stage renal disease secondary to FSGS initiates chronic maintenance hemodialysis therapy. He receives 40 μg of recombinant hepatitis B vaccine intramuscularly in the deltoid, receiving three separate doses. Six weeks after the primary series is completed, antibody levels against hepatitis B surface antigen are <10 mU/ml.


Peritoneal Dialysis Correct Answer Pediatric Nephrology Dialysis Unit Iron Sucrose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Rnagel MC, Coronado VG, Euler GI, et al. (2000) Vaccine recommendations on patient on chronic hemodialysis. Seminar 13:101–107Google Scholar
  2. Chang IM, Hwang SJ, Kuo HT, et al. (2000) Fatal outcomes after ingestion of star fruit (averrhoa, Carambola) in uremic patients. Am J Kidney Dis 35:189–193CrossRefPubMedGoogle Scholar
  3. Dheenan S, Henrich WL (2001) preventing dialysis hypotension: A comparison of usual protective measures. Kidney Int 59:1175–1181CrossRefPubMedGoogle Scholar
  4. Hutter JC, Kuehnart MJ, Willis RR, et al. (2000) Acute onset of decreased vision and hearing, traced to hemodialysis treatment with aged dialyzers. JAMA 283: 2128–2134CrossRefPubMedGoogle Scholar
  5. Oliver MJ, McCann RL, Indridason OS, et al. (2001) Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int 60:1532–1539CrossRefPubMedGoogle Scholar
  6. National Kidney Foundation (2000) K/DOQ1 Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis (suppl 1) 37:S137–S181Google Scholar
  7. Beathard GA (1999) Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10:1049–1045Google Scholar
  8. Duffy R, Tomascheck K, Spangenberger M, et al. (2000) Multicites outbreak of hemolysis in hemodialysis patients traced to faulty blood tubing sets. Kidney Int 57:1667–1674CrossRefGoogle Scholar
  9. Michael B, Coyne DW, Fishbane S, et al. (2002) Sodium gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 61:1830–1839CrossRefPubMedGoogle Scholar
  10. Van Wyck DB, Cavallo G, Spinowitz BS, et al. (2000) Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American Clinical Trial. AM J Kidney Dis 36:88–97CrossRefPubMedGoogle Scholar
  11. Gunnell J, Yeun JY, Depner TA, et al. (1999) Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33:63–72CrossRefPubMedGoogle Scholar
  12. Ahya SN, Windus DW, Vesely TM, et al. (2001) Flow in hemodialysis grafts after angioplasty: Do radiologic criteria predict success? Kidney Int 59:1974–1978CrossRefPubMedGoogle Scholar
  13. Depner TA (2002) Daily hemodialysis efficiency: An analysis of solute kinetics. Adv Ren Replace Ther 8:227–235CrossRefGoogle Scholar
  14. Frankenfield DL, McClellan WM, Helgerson SD, et al. (1999) Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in 1996 National ESRD Core Indicators Project. Am J Kidney Dis 33:584–591CrossRefPubMedGoogle Scholar
  15. Hurot JM, Cucherat M, Haugh M, et al. (2002) Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13:708–714PubMedGoogle Scholar
  16. Beaubien ER, Pylypchuk GB, Akhtar J, et al. (2002) Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis 39:834–842CrossRefPubMedGoogle Scholar
  17. Nappi SE, Virtanen VK, Saha HHT, et al. (2000) QT dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int 57:2117–2122CrossRefPubMedGoogle Scholar
  18. Karnik JA, Young BS, Hew NL, et al. (2001) Cardiac arrest and sudden death in dialysis units. Kidney Int 60:350–357CrossRefPubMedGoogle Scholar
  19. Lopes AA, Bragg-Gresham JL, Satayathum S, et al. (2003) Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 41:605–615CrossRefPubMedGoogle Scholar
  20. Allon M (2003) Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36:1539–1544CrossRefPubMedGoogle Scholar
  21. Marenzi G, Marana I, Lauri G, et al. (2003) The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349:1333–1340CrossRefPubMedGoogle Scholar
  22. Okada S, Katagiri K, Kumazaki T, et al. (2001) Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiol 42:339–341CrossRefPubMedGoogle Scholar
  23. Prince MR, Erel HE, Lent RW, et al. (2003) Gadolinium administration causes spurious hypocalcemia. Radiology 22&:639CrossRefGoogle Scholar
  24. Konings C, Kooman JP, Schonck M, et al. (2003) Effect of icodextrin on volume status, BP and echocardiographic parameters: A randomized study. Kidney Int 63:1556–1563CrossRefPubMedGoogle Scholar
  25. Burdick RA, Bragg-Gresham JL, Woods JD, et al. (2003) Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 63:2222–2229CrossRefPubMedGoogle Scholar
  26. William PF, Foggensteiner L (2002) Sterile/allergic peritonitis with icodextrin in CAPD patients. Perit Dial Int 22:89–90Google Scholar
  27. Arand S, Nissenson AR (2003) Pure red-cell aplasia (2003) An emerging epidemic in dialysis patients. Peri Dial Int 23:317–319Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Farahnak Assadi
    • 1
  1. 1.Rush University Medical CenterChicago

Personalised recommendations